Glenmark bags another FDA approval

Glenmark’s current portfolio consists of 103 products authorized for distribution in the US marketplace and 63 ANDA’s pending approval with the US FDA

id-100294534

Glenmark's drug is the therapeutic equivalent of Lotrisone Cream

Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (US FDA) for Clotrimazole and Betamethasone Dipropionate Cream USP, 1 percent|0.05 percent.

The drug is the therapeutic equivalent of Lotrisone Cream USP, 1 percent|0.05 percent of Merck, Sharp and Dohme Corporation.

According to IMS Health sales data for the 12 month period ending September 2015, the Lotrisone Cream USP, 1 percent|0.05 percent market achieved annual sales of approximately $82.4 million.

 

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X